Utilisation of Pharmacokinetic- Pharmacodynamic Modelling and Simulation in Regulatory Decision-Making

By Gobburu J.V.S.  

Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. : 883-892

Adis International

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetics Is Impacting Drug Development and Regulatory Decision Making

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 6, 2015-06 ,pp. : 313-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multigenic Control of Drug Response and Regulatory Decision-Making in Pharmacogenomics: The Need for an Upper-Bound Estimate of Genetic Contributions

By  

Current Pharmacogenomics, Vol. 3, Iss. 1, 2005-03 ,pp. : 53-71

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetics: A Regulatory Perspective

By Williams R.  

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 41-58

Adis International

Access to resources Recommend Favorite

Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome

By Lynd Larry D.   Najafzadeh Mehdi   Colley Lindsey   Byrne Michael F.   Willan Andrew R.   Sculpher Mark J.   Johnson F. Reed   Hauber A. Brett  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 411-417

Blackwell Publishing

Access to resources Recommend Favorite